ICD-10-CM Billable Code

C82.10

Follicular lymphoma grade II, unspecified site

Clinical Classification Guidelines

Medical Intelligence & Overview

Follicular lymphoma is a type of non-Hodgkin lymphoma that originates in the lymphatic system, which is part of your body's immune defense. Specifically, grade II follicular lymphoma is considered an intermediate level of aggressiveness among this group of lymphomas. It mainly affects lymph nodes but can sometimes involve other parts of the body. Being diagnosed with follicular lymphoma grade II can be concerning, but many approaches are available for management and treatment, depending on individual circumstances.

Causes & Symptoms

Clinical Causes: The exact cause of follicular lymphoma remains unknown. However, several factors may increase the risk of developing this condition: - **Genetic mutations:** Changes in certain genes within lymphocytes, the white blood cells involved, can contribute. - **Age:** It is more common in middle-aged and older adults. - **Gender:** Males are slightly more at risk than females. - **Family history:** Having relatives with lymphoma or other lymphatic cancers may increase risk. - **Environmental exposures:** Long-term exposure to certain chemicals, such as agricultural chemicals or pesticides, has been studied as potential risk factors. - **Immune system status:** Conditions that weaken the immune system, including autoimmune diseases or immunosuppressant therapy, can play a role.

Key Symptoms: Follicular lymphoma often develops slowly and may not cause clear symptoms initially. When symptoms are present, they can include: - **Swollen lymph nodes:** Painless swelling commonly in the neck, armpits, or groin. - **Fatigue:** Feeling unusually tired or weak. - **Fever and night sweats:** Frequent episodes that are not caused by infections. - **Unexplained weight loss:** Losing weight without trying. - **Itching:** Skin itchiness that doesn't have an apparent cause. - **Abdominal discomfort:** Due to enlarged lymph nodes or spleen. - **Others:** As it progresses, symptoms can become more pronounced depending on which areas are involved.

Diagnostic & Treatment

Diagnosis Path: Diagnosing follicular lymphoma involves several steps: - **Medical history and physical exam:** To check for swollen lymph nodes and general health. - **Blood tests:** To evaluate blood cell counts and overall health. - **Imaging tests:** Such as CT scans or PET scans to identify affected areas. - **Lymph node biopsy:** The definitive diagnostic step where tissue is removed and examined under a microscope to identify lymphoma cells. - **Immunophenotyping and genetic tests:** To identify specific markers and genetic features that confirm follicular lymphoma and its grade. - **Staging:** Further tests to determine the extent of spread, guiding treatment options.

Treatment Protocols: Treatment strategies for follicular lymphoma grade II aim to control the disease and manage symptoms. Options may include: - **Watchful waiting:** For some patients with minimal symptoms, regular monitoring without immediate treatment. - **Chemotherapy:** Using drugs to kill cancer cells. - **Immunotherapy:** Targeted therapies that stimulate the immune system to attack lymphoma cells. - **Radiation therapy:** Focused beams to eliminate localized disease. - **Targeted therapy:** Using medications that specifically interfere with cancer cell growth. - **Stem cell transplant:** In certain cases, especially after relapse, to restore healthy blood cell production. - **Supportive care:** Including medications to manage symptoms and side effects. The choice of treatment depends on several factors, including disease stage, patient health, and personal preferences.

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.

Clinical Advice & FAQs

Billing Guidance

Is C82.10 a billable ICD-10 code?
Yes, C82.10 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.

Documentation

How do I report C82.10?
Clinical documentation must specify the nature of Follicular lymphoma grade II, unspecified site and any associated comorbidities for accurate reporting.

Cite this Clinical Reference